| Stage | NVDA | % of rev | ARRY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $342M | 100.00% | NVDA ×281.29 |
| Gross profit | $72.1B | 74.98% | $100M | 29.12% | NVDA +45.9pp |
| Operating income | $63.7B | 66.24% | $35M | 10.16% | NVDA +56.1pp |
| Pre-tax income | $71.5B | 74.32% | $32M | 9.27% | NVDA +65.0pp |
| Net income | $59.7B | 62.03% | $24M | 7.12% | NVDA +54.9pp |
| Stage | NVDA | ARRY | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $342M100.00% | NVDA ×281.29 |
| Gross profit | 74.98%$72.1B | 29.12%$100M | NVDA +45.9pp |
| Operating income | 66.24%$63.7B | 10.16%$35M | NVDA +56.1pp |
| Pre-tax income | 74.32%$71.5B | 9.27%$32M | NVDA +65.0pp |
| Net income |
| 62.03%$59.7B |
| 7.12%$24M |
| NVDA +54.9pp |
No shared counterparties.